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Abstract
Background: Postural hypotension (PH) indicates the presence of cardiac autonomic neuropathy and in diabetes 
mellitus (DM) is associated with adverse outcome. Nonetheless, PH has been rarely characterized in young persons 
in Sub-saharan Africa where suboptimal care of DM is prevalent.
Aims: The aim of the study was to determine the prevalence of PH in young patients with type 1DM and its relationship 
with the duration of DM and glycemic control.
Settings and Design: It was a cross-sectional, case control study carried out in the pediatric out-patient clinic.
Materials and Methods: Each study participant had blood pressure (BP) measured in the supine and standing positions. 
Glycated hemoglobin (HbA1c) levels were determined and disease duration was documented.
Statistical Analysis: The mean BP in the different positions was determined. The occurrence of PH, duration of disease 
and HbA1c levels was determined with logistic regression analysis.
Results: A total of 26 diabetic subjects and 26 age and sex matched controls were studied. 12 (46.2%) diabetic subjects 
had evidence of PH while none of the controls had PH. Diabetic subjects with PH had significantly longer duration of 
DM than those diabetics without PH (6.79 ± 4.81 vs. 2.83 ± 2.36, P = 0.023). The mean HbA1c level was similar in both 
groups of diabetic subjects (9.79 ± 2.07 vs. 9.17 ± 2.35). On logistic regression, age, duration of disease, HbA1c level 
and body mass index were not significant predictors of PH.
Conclusion: PH is common in young persons with type 1 DM, with higher frequency in those with long standing disease.
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Introduction
Postural hypotension (PH), which has been defined as 
a decrease in systolic blood pressure (SBP) ≥20 mmHg 
and or a decrease in diastolic blood pressure (BP) 
≥10 mmHg, respectively within 3 min of standing is 
believed to be one of the dramatic clinical manifestation 
and hallmark of diabetic autonomic neuropathy.[1,2] It is 
believed to be one of the tests of sympathetic autonomic 
dysfunction that can be demonstrated in patients with 
diabetes mellitus (DM).[3] The phenomenon predicts 
significant adverse effects such as sudden death and renal 
failure.[4,5] In adults with DM, in whom PH has been 
well‑characterized, it may reflect the impact of ageing, 
poor diabetic control or both and the prevalence has been 
reported to be between 3% and 35%.[6‑8] Gyang et al.[9] 
while describing the complications of diabetes in a cohort 
of 283 diabetics (type 2 and type 1) in Jos, Nigeria 
documented prevalence of 3.9%. Eze et al.[10] on the 
other hand, noted that PH as detected by BP response to 
standing had the best positive predictive value of cardiac 
autonomic neuropathy (CAN) in the cohort of type 2 
diabetics studied in Enugu.
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On the other hand, in children, PH may relate to poor long 
term glycemic control with minimal effect of ageing.[8,11] In 
contrast to adults, few studies have characterized PH in 
children, in whom type 1 DM predominates.[6,11] Moreover, 
the few studies detailing PH in children were carried out 
in the developed regions of the world. Extrapolating these 
data to young persons with DM in developing countries of 
the world may be fraught with errors. One major reason for 
this is the suboptimal care many children in these countries 
receive; partly as a result of family poverty, competing needs 
at the household level and poorly resourced health facilities. 
Hence, these children are more likely to develop short‑ and 
long‑term complications of DM including autonomic 
dysfunction. Thus, this study was aimed at determining 
the prevalence of PH and its associated risk factors among 
a cohort of young persons with DM.
Materials and Methods
A total of 26 consecutive patients with type 1 DM attending 
the Pediatric Diabetic Clinic of the Lagos University 
Teaching Hospital (LUTH) between July 2010 and 
February 2011 were the subjects for this study. The study 
was undertaken after ethical approval from the Health 
Research and Ethics Committee of LUTH was obtained. 
The caregiver of each subject or the subject (if 18 years 
or older) provided informed consent before enrolment 
in the study. All subjects were diagnosed with type I DM 
according to World Health Organization criteria[12] and 
received mixed insulin 70/30 twice‑a‑day. The subjects 
were also on twice daily monitoring of blood glucose 
at home and quarterly glycated hemoglobin (HbAIc) 
monitoring. Apparently healthy age and sex matched 
controls without any known structural heart disease, 
metabolic or chronic disease or acute illness, with normal 
blood glucose (70‑110 mg/dl) and HbA1c (4.5‑6.5%) were 
also recruited. Subjects with any acute illness (including 
febrile illnesses, diabetic ketoacidosis and gastroenteritis), 
a known structural heart disease and those on any 
antihypertensive were excluded.
This study focused on determining PH with change in the BP 
with posture which basically reflects sympathetic autonomic 
dysfunction. Each study participant had their weight and 
height measured during a routine clinic visit and the body 
mass index (BMI) was determined. After remaining calm 
and supine on an examining couch for 5 min, BP was taken 
on the right hand using a mercury sphygmomanometer with 
an appropriate cuff as recommended by the Fourth Report 
on the diagnosis, evaluation and treatment of high blood 
pressure (BP) in children and adolescents.[13] Thereafter, 
the subject was asked to stand for 3 min and then the BP 
measurement repeated. The mercury levels at the first and 
fifth Korotkoff sounds were taken as the systolic and diastolic 
BP. Two BP measurements were taken in the supine and also 
in the standing position and the average of the readings was 
taken as the BP for each position. The BP was measured 
twice when supine and when standing and the average of 
the two readings was used to determine the presence of PH.
Definition of terms
Normal BP was defined as SBP and diastolic blood 
pressure (DBP) values less than 90th percentile for the child’s 
age, sex and height.[13]
PH was defined as a decrease in SBP ≥20 mmHg and/or a 
decrease in diastolic BP ≥10 mmHg.[6]
Hypertension was defined as BP >95th centile for age, sex 
and height.[13]
Determination of microalbuminuria and glycated 
hemoglobin
Urine and blood samples were collected from each subject 
for determination of microalbuminuria and HbA1c levels 
respectively.
Microalbuminuria was determined by dipping a micral 
strip into freshly collected urine sample and read using a 
visual analog scale. The glycated HbA1c was measured 
using the Clover A1C Analyzer, which uses the reflectance 
spectrophotometer method.
Statistical analysis
Categorical and continuous data were summarized as 
proportions and mean (SD) respectively. Chi‑square test 
was used to test the differences between categorical data 
and student t test was used for continuous data. Logistic 
regression analysis was used to identify predictors of PH. In 
all statistical tests, a P < 0.05 in two tails was considered 
significant.
Results
The study population comprised of 26 subjects and 26 aged 
and sex matched controls.
Table 1 shows the clinical characteristics of subjects 
with diabetes and non‑diabetic controls. Subjects with 
diabetes had significantly higher diastolic BPs both in the 
supine (P = 0.001) and standing positions (P = 0.013). 
However, there were no significant differences between 
subjects with diabetes and control subjects in age, sex and 
BMI.
The mean duration of DM was 5.0 ± 4.3 years and the 
mean HbA1c level was 9.5 ± 2.2% in the diabetic subjects. 
Postural hypertension was observed in 12 (46.15%) of 
the diabetic subjects. Two of the diabetic subjects were 
hypertensive and one of these also had PH. However, none 
of the controls had PH.
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Comparison of subjects with PH and without PH
Table 2 shows a comparison of the study participants with and 
without hypotension. The diabetic subjects with hypotension had 
a statistically significant longer duration of illness (P = 0.023) 
than those diabetics without PH. Similarly, the mean SBP in the 
supine position (117.2 ± 4 versus 111.04 ± 11.3) and standing 
position (115.7 ± 14.7 versus 103.0 ± 8.1) were significantly 
higher in the diabetic subjects with hypotension than those 
without (P = 0.023 and P = 0.035 respectively). The diastolic 
BP was however similar in both groups.
The mean HbA1c was similar in the diabetic subjects with 
and without PH. The urinary albumin level was higher in the 
group with PH, but this did not reach statistical significance 
level (31.7 ± 27.6 versus 17.1 ± 23.6).
Relationship between PH, glycemic control and 
duration of illness
Table 3 shows a comparison of duration of illness and 
glycated HbA1c levels in the diabetic subjects with and 
without PH, 8 (66.7%) of the 12 subjects with PH had 
HbA1c levels greater than 9% with significantly poor 
metabolic control. 9 (75%) of the subjects with PH also 
had a duration of illness longer than 5 years. The duration 
of illness was also significantly related to the occurrence of 
PH (Chi‑square value = 4.013, P = 0.043).
Predictors of PH [Table 4]
None of the parameters (i.e., Age, BMI, Duration of DM, 
HbA1c) tested was able to significantly predict PH in this 
cohort of diabetic subjects.
Discussion
Our study shows a high prevalence of PH (41.5%) among 
young persons with DM compared with the non‑diabetic 
subjects who did not have any evidence of PH.
This prevalence is significantly higher than those reported in 
studies of persons with type 1 DM.[4,14,15] it is however to be 
noted that the highest prevalence of PH has been observed 
amongst hospitalized individuals (52‑69%) and the lowest 
among community‑dwelling individuals (5‑30%).[16,17] The 
wide differences in the reported prevalence of PH may be 
partly explained by the differences in the study population 
and definition of PH. To minimize this we adopted the 
recent consensus on the definition of PH as a drop in blood 
pressure of at least 20 mmHg systolic or 10 mmHg diastolic 
within 3 min of either standing or head‑up tilt of at least 
60°.[6,18] This may have contributed to the higher prevalence 
of PH in the present study. A higher prevalence has also 
been observed by other researchers when the standing BP 
is taken 3 min after standing compared to when the BP is 
taken 1 min after standing.[4] BP changes to posture has 
been observed to be a reliable indicator of sympathetic 
autonomic dysfunction even in diabetic patients.[10] Other 
workers have demonstrated the presence of PH with heart 
rate variability, but this was not evaluated in this study. 
Table 1: Clinical characteristics of the study 
participants





Age (years) 13.2±5.3 11.2±6.0 0.222
Sex M (16), F (10) M (16), F (10) -
BMI (kg/m2) 19.9±3.4 18.3±2.3 0.443
Duration of DM (years) 5.0±4.3 - -
Supine SBP (mmHg) 110.2±12.9 104.5±8.0 0.070
Supine DBP (mmHg) 74.6±10.9 65.8±6.0 0.001
Standing SBP (mmHg) 109.5±13.3 103.1±10.6 0.081
Standing DBP (mmHg) 73.4±20.2 66.73±7.8 0.013
HbA1C (%) 9.5±2.2 - -
Continuous data are mean±SD unless otherwise stated. P values are 
for the difference between the diabetic subjects and the controls. 
Blood sugar‑Mean monthly fasting blood sugar. SPB=Systolic blood 
pressure; DPB=Diastolic blood pressure; HbA1c=Glycated hemoglobin; 
DM=Diabetes mellitus; BMI=Body mass index
Table 2: Comparison of clinical and laboratory features of study participants with and without hypotension
Parameters Diabetic PH 
(n=12; 46.2%)
Subjects no PH 
(n=14; 53.8%)




Age (years) 14.7±4.9 11.4±5.4 0.12 - 11.2±6.0
Sex M (5), F (7) M (11), F (3) - - M (16), F (10)
BMI (kg/m2) 20.3±3.6 19.3±3.7 0.53 - 19.8±2.3
Duration of DM (years) 6.8±4.8 2.8±2.4 0.02 - -
Supine SBP (mmHg) 117.2±11.4 104.3±11.3 0.02 - 104.5±8.0
Supine DBP (mmHg) 77.4±10.8 72.0±11.4 0.30 - 65.8±6.0
Standing SBP (mmHg) 115.7±14.7 103.0±8.1 0.04 - 103.1±10.6
Standing DBP (mmHg) 81.2±10.5 60.8±28.1 0.05 - 66.73±7.8
HbA1C (%) 9.8±2.1 9.2±2.4 0.53 - -
Blood sugar (mg/dl) 123.33±8.22 116.14±9.55 0.05 - -
Urinary albumin (mg/dl) 31.7±27.6 17.1±23.6 0.26 - -
Continuous data are mean±SD unless otherwise stated. P values are for the difference between the diabetic subjects with and without postural hypotension. 
Blood sugar‑Mean monthly fasting blood sugar. SPB=Systolic blood pressure; DPB=Diastolic blood pressure; HbA1c=Glycated hemoglobin; PH=Postural 
hypotension; DM=Diabetes mellitus; BMI=Body mass index
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The absence of PH in the controls in this study may not be 
entirely surprising as this phenomenon is not a common 
occurrence in normal children compared to adults where 
the presence of PH has been explained by ageing, drugs and 
other adult onset neuropathies.
The poor glycemic control observed in the cohort in this 
study may also explain the high prevalence of PH observed. 
The mean HbA1c and fasting glucose level of 9.5% and 
120 mg% respectively underscores this observation. 
The similarity between the mean HbA1c in the diabetic 
subjects with PH and without PH may suggest the lack of 
an association between PH and mean HbA1c. However, 
the mean HbA1c for the cohort was high, thus when 
the subjects were grouped according to the presence or 
absence of PH the positive/significant effect of HbA1c 
on PH was not apparent. Although, the study did not 
explore reasons for poor glycemic control, non‑adherence 
to life‑style modification measures and insulin therapy 
commonly explain it. In a developing country, such as 
Nigeria non‑adherence is aggravated by family poverty, self 
and family denial of disease and ignorance about the nature 
of DM. The vast majority of the subjects in this study being 
adolescents may also have explained the poor glycemic 
control. In general, adolescence represents a vulnerable 
period for non‑adherence to treatment plans and a period 
when significant adverse outcomes occur in persons with 
chronic illnesses such as DM and chronic renal failure.[19]
Long standing poor glycemic control pre‑disposes patients 
to microvascular complications and autonomic neuropathy, 
of which PH is one.[20‑22] This results from damage to the 
efferent sympathetic vasomotor fibers, particularly in the 
splanchnic vasculature.[23] In addition, there is a decrease 
in cutaneous, splanchni and total vascular resistance that 
occurs in the pathogenesis of this disorder.[24] PH may 
therefore serve as a marker of autonomic neuropathy 
in this cohort of patients. Similar observations on poor 
glycemic control and the occurrence of  CAN has been 
documented by Odusan et al.[25] in type 2 diabetics in 
Nigeria. It is important to note that the diabetic in our 
study were asymptomatic as none complained of the known 
symptoms of PH. Such symptoms are dizziness, weakness, 
fatigue, visual blurring and neck pain. This is not unusual as 
adults who have a longer duration of diabetes usually remain 
asymptomatic despite significant falls in blood pressure.[26]
Long standing DM was also observed to be significantly 
associated with PH in our study. The subjects with PH had 
a longer duration of diabetes compared with those without 
PH (6.79 ± 4.81, vs. 2.83 ± 2.36 years, P = 0.023). It was 
also observed that 9 (75%) of the subjects with PH actually 
had duration of disease above 5 years. There is increased 
likelihood of poorer adherence with longer duration of 
illness. It is a known fact that diabetes with duration above 
5 years is more associated with complications especially 
when this occurs with poor metabolic control. In addition, 
the longer the duration of DM, the more likely that the 
impact of poor glycaemic control will reflect as clinically 
recognizable complications.[6]
PH in diabetes has also been linked to the presence 
of  microalbuminur ia  and other  microvascular 
complications.[27‑28] However, in our study, the positive 
relationship between PH and microalbuminuria was weak. 
Like PH and retinopathy, microalbuminuria indicates the 
presence of microvascular damage in persons with DM and 
being an early predictor of kidney damage represents an 
important screening tool in reducing renal complications 
of DM. However, when the parameters were put to multiple 
logistic regression analysis none could independently predict 
the occurrence of PH, indicating the possible presence of 
some unexplored predictors of PH in the study. The reason 
for this is not clear, but could be explained by the small 
number of subjects in the study.
In this study, the SBP readings in the supine and standing 
position were significantly higher in subjects with PH 
than those without PH and this observation has also been 
made by other workers.[4,19,26] The reason for this however 
remains unclear and this occurrence may due to individual 
idiosyncrasy or peculiarities. However, the presence of 
both elevated SBP and PH in the same individual makes 
treatment of hypertension difficult as such measures worsen 
the magnitude of the PH.
Table 3: Glycated hemoglobin levels and duration of 
illness in diabetic subjects with and without postural 
hypotension
Parameters PH n (%)
12 (100)






<6.5 0 (0) 1 (7.2) 1 (3.8) 0.057
6.5-9 4 (33.3) 10 (71.4) 14 (53.8)
>9 8 (66.7) 3 (21.4) 11 (42.4)
Duration of illness
<5 years 3 (25) 11 (78.6) 14 (53.8) 0.043
>5 years 9 (75) 3 (21.4) 12 (46.2)
PH=Postural hypotension; HbA1c=Glycated hemoglobin levels
Table 4: Multiple regression analysis showing 
independent predictors of postural hypotension in 
diabetes subjects
Parameter OR (95% CI) P value
Age (year) 0.96 (0.63-1.47) 0.88
BMI (kg/m2) 1.07 (0.36-3.16) 0.90
Duration of DM 0.58 (0.17-1.99) 0.39
HbA1c (%) 0.61 (0.11-3.31) 0.57
Blood sugar (mg/dl) 0.80 (0.62-1.03) 0.09
OR (95% CI) refers to odds ratio (95% confidence interval values), P <0.05 
are considered as significant. Blood sugar‑Mean monthly fasting blood 
sugar. BMI=Body mass index; DM=Diabetes mellitus; HbA1c=Glycated 
hemoglobin; CI=Confidence interval; OR=Odds ratio
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Limitations
Our study has some limitations; one is the small sample 
size, which limits extrapolation of the findings; however, our 
clinic is one of the largest in Nigeria and all eligible subjects 
were recruited. The use of the Tilt table to determine the 
presence of PH was not possible in the study due to its 
unavailability. It would have been desirable to repeat the 
BP readings in the study cohort, but some had been lost 
to follow‑up and thus the persistence of PH could not be 
ascertained. Presence of PH over several days may carry 
more significant clinical implications.
Conclusion
This study documents a high prevalence of PH among 
young persons with DM in Nigeria. The mean HbA1c level 
indicates a poor glycemic control among our population of 
children with DM; thus, measures targeted at improving 
diabetic care should be emphasized. PH was strongly related 
to the duration of DM.
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